Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 47 (3), 166-74

[Microcytic and Hypochromic Anemias]

[Article in Czech]
Affiliations
  • PMID: 15635879
Review

[Microcytic and Hypochromic Anemias]

[Article in Czech]
L Chrobák. Vnitr Lek.

Abstract

In the majority of cases, microcytosis is the result of impaired hemoglobin synthesis. Disorders of iron metabolism and protoporphyrin and heme synthesis, as well as impaired globin synthesis, lead to defective hemoglobin production and to the generation of microcytosis and microcytic anemia. Iron deficiency anemie, anemia of chronic diseases, thalassemias, congenital sideroblastic anemias and homozygous HbE disease are the main representatives of microcytosis and microcytic anemias. Serum iron, total iron binding capacity, transferrin saturation, serum ferritin, serum transferrin receptor, transferrin receptor-ferritin index, and zinc-protoporhyrin concentration in erythrocytes are tests used for assessment of iron deficiency. The convention laboratory test for diagnosing iron deficiency is the measurement of serum ferritin. The most precise method for evaluating body iron stores is the examination for iron on aspirated bone marrow or marrow biopsy. Increased content of Hb A2 over 3.5% is diagnostic for beta-thalassemia. Presence of ringed sideroblasts is characteristic of sideroblastic anemias. Hemoglobin electrophoresis is required for the diagnosis of hemoglobinopathy E. The optimal therapeutic regimen in iron deficiency anemia used in this country is to administer 100 mg of elemental iron twice daily separately from meals. Ferrous sulphate (Ferronat Retard tbl. or Sorbifer Dulures tbl.) which are slow-releasing iron formulations are preferred because of their low cost, high bioavailability and low side-effects. Parenteral iron therapy is justified only in patients who cannot absorb iron, who have blood losses that exceed the maximal absorptive capacity of their intestinal tract or who are totally intolerant of oral iron. However, parenteral iron therapy may be associated with serious and even fatal side-effects.

Similar articles

  • Serum Ferritin in Beta-Thalassemia Trait
    A Loria et al. Isr J Med Sci 14 (11), 1127-31. PMID 750537.
    The diagnostic value of serum ferritin measurements in discriminating iron-deficiency anemia from thalassemia trait has been studied. In contrast to serum iron, percent t …
  • Microcytic Anemia
    JW Shine. Am Fam Physician 55 (7), 2455-62. PMID 9166144.
    Because anemia is a condition rather than a disease, an underlying cause must be determined when anemia is identified. Microcytic anemia is a common category of anemia. I …
  • α-Thalassemia Frequency and Mutations in Children With Hypochromic Microcytic Anemias and Relation With β-Thalassemia, Iron Deficiency Anemia
    H Gulen et al. Pediatr Hematol Oncol 29 (3), 241-6. PMID 22475300.
    The majority of the anemias during childhood are hypochromic and microcytic. The aim of the present study was to determine the status of α-thalassemia mutations and its a …
  • Iron Deficiency Anemia
    S Killip et al. Am Fam Physician 75 (5), 671-8. PMID 17375513. - Review
    The prevalence of iron deficiency anemia is 2 percent in adult men, 9 to 12 percent in non-Hispanic white women, and nearly 20 percent in black and Mexican-American women …
  • Diagnosis and Management of Iron-Deficiency Anaemia
    JD Cook. Best Pract Res Clin Haematol 18 (2), 319-32. PMID 15737893. - Review
    Anaemia is typically the first clue to iron deficiency, but an isolated haemoglobin measurement has both low specificity and low sensitivity. The latter can be improved b …
See all similar articles

LinkOut - more resources

Feedback